Melanoma
Immune response to at least two melanoma peptides improves long-term outcomes
Published in Cancer Vaccine Week, August 28th, 2006
According to a study from the United States, "Between March 1999 and May 2000, 18 HLA-A*0201+ patients with metastatic melanoma were enrolled in a phase I trial using a dendritic cell (DC) vaccine generated by culturing CD34+ hematopoietic progenitors. This vaccine includes Langerhans cells."
"The DC vaccine was loaded with four melanoma peptides (MART-1/MelanA, tyrosinase, MAGE-3, and gp100), influenza matrix peptide (Flu-MP), and keyhole limpet hemocyanin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
Source: Cancer Vaccine Week (2006-08-28)
More Articles from Cancer Vaccine Week
- Cancer Vaccine
Antitumor efficacy of tumor cell vaccine is not inhibited by docetaxel - Glioma
Monocytes of patients with glioma can generate mature dendritic cells - Melanoma
Antitumor immunity was induced by dendritic cells pulsed with anti-CD44 tumor cells - Pancreatic Cancer
Oncolysis of pancreatic tumor cells by gamma 34.5-deleted HSV-1 relies on PI 3-kinase pathway - Brain Tumors
Brain tumor response to temozolomide studied in pediatric patients - Breast Cancer
Breast cancer could be inhibited by preventing geranylgeranylation of Rho - More from this issue of Cancer Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
